tradingkey.logo

AxoGen Inc

AXGN
35.080USD
+0.060+0.17%
取引時間 ET15分遅れの株価
1.62B時価総額
損失額直近12ヶ月PER

AxoGen Inc

35.080
+0.060+0.17%

詳細情報 AxoGen Inc 企業名

Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.

AxoGen Incの企業情報

企業コードAXGN
会社名AxoGen Inc
上場日Dec 17, 1986
最高経営責任者「CEO」Dale (Michael Donald)
従業員数451
証券種類Ordinary Share
決算期末Dec 17
本社所在地13631 Progress Blvd.
都市ALACHUA
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号32615
電話番号13864626817
ウェブサイトhttps://www.axogeninc.com/
企業コードAXGN
上場日Dec 17, 1986
最高経営責任者「CEO」Dale (Michael Donald)

AxoGen Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
31.38K
+10613.00%
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
27.03K
+14344.00%
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
--
--
Ms. Amy A. Mcbride-Wendell
Ms. Amy A. Mcbride-Wendell
Lead Independent Director
Lead Independent Director
--
--
Mr. Alan M. Levine
Mr. Alan M. Levine
Independent Director
Independent Director
--
--
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
--
-21399.00%
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
Mr. William P. (Bill) Burke
Mr. William P. (Bill) Burke
Independent Director
Independent Director
--
--
Dr. Joseph (Adrian) Tyndall, M.D.
Dr. Joseph (Adrian) Tyndall, M.D.
Independent Director
Independent Director
--
--
Mr. Marc A. Began
Mr. Marc A. Began
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
31.38K
+10613.00%
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
27.03K
+14344.00%
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
--
--
Ms. Amy A. Mcbride-Wendell
Ms. Amy A. Mcbride-Wendell
Lead Independent Director
Lead Independent Director
--
--
Mr. Alan M. Levine
Mr. Alan M. Levine
Independent Director
Independent Director
--
--
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
--
-21399.00%

収益内訳

FY2023
FY2022
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
United States
159.01M
0.00%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Fri, Jan 2
更新時刻: Fri, Jan 2
株主統計
種類
株主統計
株主統計
比率
First Light Asset Management, LLC
11.58%
BlackRock Institutional Trust Company, N.A.
6.34%
The Vanguard Group, Inc.
5.70%
Morgan Stanley & Co. LLC
4.56%
ArrowMark Colorado Holdings, LLC
3.91%
他の
67.90%
株主統計
株主統計
比率
First Light Asset Management, LLC
11.58%
BlackRock Institutional Trust Company, N.A.
6.34%
The Vanguard Group, Inc.
5.70%
Morgan Stanley & Co. LLC
4.56%
ArrowMark Colorado Holdings, LLC
3.91%
他の
67.90%
種類
株主統計
比率
Investment Advisor/Hedge Fund
37.23%
Investment Advisor
27.86%
Hedge Fund
13.23%
Research Firm
5.95%
Individual Investor
2.50%
Family Office
1.62%
Bank and Trust
0.41%
Pension Fund
0.30%
Sovereign Wealth Fund
0.12%
他の
10.77%

機関投資家保有株

更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
342
42.08M
97.83%
+8.74K
2025Q3
350
42.06M
101.71%
+627.35K
2025Q2
344
41.40M
98.61%
+1.26M
2025Q1
339
40.15M
93.21%
-2.27M
2024Q4
327
37.35M
99.16%
-1.08M
2024Q3
305
37.98M
92.55%
+3.00M
2024Q2
285
37.71M
96.69%
+1.44M
2024Q1
290
36.54M
95.40%
-4.68M
2023Q4
299
34.97M
92.73%
+437.14K
2023Q3
304
34.60M
92.75%
-2.09M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
First Light Asset Management, LLC
5.81M
12.59%
+1.28M
+28.18%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.18M
6.89%
+76.53K
+2.47%
Sep 30, 2025
The Vanguard Group, Inc.
2.67M
5.79%
-51.00K
-1.87%
Sep 30, 2025
Morgan Stanley & Co. LLC
2.29M
4.96%
+352.54K
+18.22%
Sep 30, 2025
ArrowMark Colorado Holdings, LLC
1.96M
4.25%
+332.50K
+20.45%
Sep 30, 2025
Soleus Capital Management, L.P.
1.73M
3.74%
+267.16K
+18.31%
Sep 30, 2025
Wasatch Global Investors Inc
1.64M
3.55%
+205.57K
+14.34%
Sep 30, 2025
Assenagon Asset Management S.A.
1.29M
2.79%
+265.95K
+25.99%
Sep 30, 2025
Balyasny Asset Management LP
1.38M
2.99%
-551.52K
-28.56%
Sep 30, 2025
Armistice Capital LLC
1.20M
2.6%
+88.68K
+7.98%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
ROBO Global Healthcare Technology & Innovation ETF
3.51%
State Street SPDR S&P Health Care Equipment ETF
2.3%
iShares Neuroscience and Healthcare ETF
2.11%
Invesco Dorsey Wright Healthcare Momentum ETF
0.97%
Invesco NASDAQ Future Gen 200 ETF
0.74%
JPMorgan Fundamental Data Science Small Core ETF
0.21%
iShares Micro-Cap ETF
0.19%
Fidelity Enhanced Small Cap ETF
0.18%
Principal U.S. Small-Cap ETF
0.15%
Franklin US Small Cap Multifactor Index ETF
0.14%
詳細を見る
ROBO Global Healthcare Technology & Innovation ETF
比率3.51%
State Street SPDR S&P Health Care Equipment ETF
比率2.3%
iShares Neuroscience and Healthcare ETF
比率2.11%
Invesco Dorsey Wright Healthcare Momentum ETF
比率0.97%
Invesco NASDAQ Future Gen 200 ETF
比率0.74%
JPMorgan Fundamental Data Science Small Core ETF
比率0.21%
iShares Micro-Cap ETF
比率0.19%
Fidelity Enhanced Small Cap ETF
比率0.18%
Principal U.S. Small-Cap ETF
比率0.15%
Franklin US Small Cap Multifactor Index ETF
比率0.14%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI